Citations

Mayo Clinic

Clear

1113 citation(s) found for "Wu, Robin".

Survival of Staphylococcus epidermidis in Fibroblasts and Osteoblasts
Perez, Kimberly , Patel, Robin , Patel, Robin

Infection and Immunity | July 31, 2018 | Volume: 86 | Issue: 10 | Pages: No page available

10.1128/iai.00237-18 | PMID 30061380 Get It

Staphylococcus epidermidis is a leading cause of infections associated with indwelling medical devices, including prosthetic joint infection. While biofilm formation is assumed to be the main mechanism underlying the chronic infections S. epidermidis causes, we hypothesized that S. epidermidis also evades immune killing, contributing to its pathogenesis.
Cyanide-Nitroprusside Colorimetric Assay: A Rapid Colorimetric Screen for Urinary Cystine
Brady, Clayton , Giesen, Callen D., Voskoboev, Nikolay, Chirackal, Robin S., Gavrilov, Dimitar K. , Flanagan, Ryan M, Brady, Clayton T , Lieske, John C.

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 2 | Issue: 1 | Pages: 55-64

10.1373/jalm.2016.022582 | PMID 33636959 Get It

Abstract Background Cystinuria is an autosomal recessive disorder resulting in poor proximal tubule reabsorption of cystine in the nephron, increasing the risk of cystine stone formation. A fast, inexpensive assay to screen for urinary cystine is needed because cystine stones are difficult to noninvasively differentiate from more common calcium-containing ones. Tandem mass spectrometry (MS/MS) is sensitive and specific but is labor-intensive and costly. Alternatively, a colorimetric assay is fast and cost-effective; however, creatinine interference is an issue. Methods A published cyanide-nitroprusside colorimetric assay was modified for a high-throughput microplate format. Creatinine interference was reduced using 0.1 mol/L PBS and a standard reaction time of 60 s and was further corrected using a formula derived from the slope of multiple creatinine standard curves. Results The limit of blank was determined to be 2.6 mg/L, the limit of detection 11.9 mg/L, and the limit of quantitation 15.3 mg/L. The analytic measurement range was established as 15.3–100 mg/L cystine. Intraassay and interassay CV was calculated to be 9.6% and 8.0%, respectively, for a high-level cystine concentration (83.6 mg/L). Low-level cystine (36.4 mg/L) intraassay and interassay CV was determined to be 18.1% and 17.6%, respectively. Passing–Bablok regression analysis of colorimetric vs LC-MS/MS results revealed a slope of 1.10 and y intercept of −7.14 mg/L, with an overall bias of 2% by Bland–Altman plot analysis. Conclusions We analytically validated a rapid colorimetric assay suitable to quantify urinary cystine. The effect of thiol drugs on this assay remains to be determined.
Executive Summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline—Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients
Jannetto, Paul J. , Bratanow, Nancy C, Clark, William , Hamill-Ruth, Robin J. , Hammett‐Stabler, Catherine A. , Kassed, Cheryl A., McMillin, Gwendolyn A. , Melanson, Stacy E.F. , Langman, Loralie J., Clark, William A, Huestis, Marilyn Ann

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 2 | Issue: 4 | Pages: 489-526

10.1373/jalm.2017.023341 | PMID 33636890 Get It

DRESS Following FIRES: A Clinical Conundrum
Dahl, Amanda , Knoebel, Erin E., Lloyd, Robin M. , Dahl, Amanda R

Clinical Pediatrics | July 16, 2018 | Volume: 57 | Issue: 12 | Pages: 1479-1482

10.1177/0009922818787321 | PMID 30010401 Get It

Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays
Karau, Melissa J. , Raval, Yash S. , Patel, Robin , Yan, Qun , Patel, Robin , Yan, Qun , Raval, Yash S.

Antimicrobial Agents and Chemotherapy | July 13, 2018 | Volume: 62 | Issue: 10 | Pages: No page available

10.1128/aac.00943-18 | PMID 30012765 Get It

The antibiofilm activity of oritavancin in combination with rifampin, gentamicin, or linezolid was evaluated against 10 prosthetic joint infection (PJI)-related methicillin-resistant Staphylococcus aureus (MRSA) isolates by time-kill assays. Oritavancin combined with rifampin demonstrated statistically significant bacterial reductions compared with those of either antimicrobial alone for all 10 isolates ( P ≤ 0.001), with synergy being observed for 80% of the isolates.
Redefining and reinvigorating the role of physics in clinical medicine: A Report from the AAPM Medical Physics 3.0 Ad Hoc Committee
Samei, Ehsan , Pawlicki, Todd , Bourland, Daniel, Chin, Erika, Das, Shiva K., Fox, Mary Kay , Freedman, D. Jay, Hangiandreou, Nicholas J., Jordan, David W. , Martin, Melissa , Pavlicek, William , Pavord, Daniel, Schober, Lisa, Thomadsen, Bruce , Whelan, Brendan , Hangiandreou, Nicholas, Fox, Mary, Miller, Robin June

Medical Physics | July 10, 2018 | Volume: 45 | Issue: 9 | Pages: No page available

10.1002/mp.13087 | PMID 29992598 Get It

Derived from 2 yr of deliberations and community engagement, Medical Physics 3.0 ( MP 3.0) is an effort commissioned by the American Association of Physicists in Medicine ( AAPM ) to devise a framework of strategies by which medical physicists can maintain and improve their integral roles in, and contributions to, health care and its innovation under conditions of rapid change and uncertainty. Toward that goal, MP 3.0 advocates a broadened and refreshed model of sustainable excellence by which medical physicists can and should contribute to health care. The overarching conviction of MP 3.0 is that every healthcare facility can benefit from medical physics and every patient's care can be improved by a medical physicist. This large and expansive challenge necessitates a range of strategies specific to each area of medical physics: clinical practice, research, product development, and education. The present paper offers a summary of the Phase 1 deliberations of the MP 3.0 initiative pertaining to strategic directions of the discipline primarily but not exclusively oriented toward the clinical practice of medical physics in the United States.
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases
Gentile, Massimo , Reda, Gianluigi , Mauro, Francesca Romana , Rossi, Davide , Renzo, Nicola Di , Molica, Stefano , Angrilli, F., Chiarenza, Annalisa , Cutrona, Giovanna , Chaffee, Kari G. , D’Arrigo, Graziella , Vigna, Ernesto , Recchia, Anna Grazia , Gaïdano, Gianluca , Raimondo, Francesco Di , Fais, Franco , Foà, Robin , Neri, Antonino , Rabe, Kari G. , Gentile, Massimo , Reda, Gianluigi , Mauro, Francesca R , Molica, Stefano , Chiarenza, Annalisa , Gaidano, Gianluca , Morabito, Fortunato , Shanafelt, Tait D. , Parikh, Sameer A. , Tripepi, Giovanni Luigi , Cortelezzi, Agostino , Ferrarini, Manlio

American Journal of Hematology | July 9, 2018 | Volume: 93 | Issue: 9 | Pages: No page available

10.1002/ajh.25206 | PMID 29984867 Get It

History of the World Society for Pediatric and Congenital Heart Surgery: The First Decade
Tchervenkov, Christo I., Kurosawa, Hiromi, Mavroudis, Constantine , Jatene, Marcelo Biscegli , Al‐Halees, Zohair , Çïçek, Sertaç , Sandoval, Néstor , Backer, Carl L., Cervantes, Jorge , Edwin, Frank , Finucane, Kirsten , Iyer, Krishna, Kinsley, Robin H. , Kreutzer, Christián , Liu, Jinfen , Maruszewski, Bohdan , Sarris, George E. , Jonas, Richard A. , Çiçek, Sertaç M, Jacobs, Jeffrey P. , Stellin, Giovanni , Dearani, Joseph A. , Ebels, Tjark , Fragata, José , Kirklin, James K. , Louis, James D. St.

World Journal for Pediatric and Congenital Heart Surgery | June 26, 2018 | Volume: 9 | Issue: 4 | Pages: 392-406

10.1177/2150135118775962 | PMID 29945512 Get It

The World Society for Pediatric and Congenital Heart Surgery (WSPCHS) is the largest professional organization in the world dedicated to pediatric and congenital heart surgery. The purpose of this article is to document the first decade of the history of WSPCHS from its formation in 2006, to summarize the current status of WSPCHS, and to consider the future of WSPCHS. The WSPCHS was incorporated in Canada on April 7, 2011, with a head office in Montreal, Canada. The vision of the WSPCHS is that every child born anywhere in the world with a congenital heart defect should have access to appropriate medical and surgical care. The mission of the WSPCHS is to promote the highest quality comprehensive cardiac care to all patients with congenital heart disease, from the fetus to the adult, regardless of the patient’s economic means, with an emphasis on excellence in teaching, research, and community service.
Diagnostic Approach for Classic Compared With Localized Whipple Disease
Crews, Nicholas R. , Pritt, Bobbi S. , Patel, Robin , Virk, Abinash, Patel, Robin , Pritt, Bobbi S , Cawcutt, Kelly , Virk, Abinash

Open Forum Infectious Diseases | June 12, 2018 | Volume: 5 | Issue: 7 | Pages: No page available

10.1093/ofid/ofy136 | PMID 29992176 Get It

Abstract Background Whipple disease (WD), a rare systemic infection caused by Tropheryma whipplei, can be a diagnostic challenge due to its variable presentation. The role of T. whipplei polymerase chain reaction (PCR) is unclear as small bowel biopsy with Periodic acid-Schiff (PAS) staining remains the diagnostic gold standard. Individualized diagnostic approaches based on variable clinical manifestations are underutilized. We investigated the methodologies employed at our institution to diagnose WD. Methods We retrospectively collected all cases of WD diagnosed from 1994 to 2016. Microbiology laboratory and anatomic pathology databases were queried. Case characteristics and disease clinical phenotypes (classical, localized WD arthritis, and localized central nervous system [CNS] disease) were described. The diagnostic approach and testing yield were analyzed and reported. Results Thirty-three cases of WD were diagnosed (18 classic WD [CWD], 9 localized WD arthritis [LWD], 6 CNS WD). Misdiagnosis and delay in diagnosis were frequent. Diagnostic approach and test yield differed by classical vs localized WD involvement. Small bowel tissue biopsy PAS stain/PCR was overwhelmingly positive (86%/92%) in CWD, yet seldom positive (12%/42%) in LWD (P < .001). Affected joint synovial fluid PCR was frequently positive in both CWD (100%, 3/3) and LWD (85%, 6/7). Conclusions These results support the role of small bowel biopsy PAS stain/PCR in the diagnosis of CW, though this approach may be of limited utility in LWD or CNS WD without gastrointestinal symptoms. Affected joint synovial fluid or cerebrospinal fluid PCR was frequently positive in both CWD and LWD, supporting its diagnostic usefulness.